Table 1 Baseline characteristics and Fisher's exact test results.

From: Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma

Characteristics

Total

Responder

Non-responder

p value

Sex

Male

45

25

20

0.567

Female

15

7

8

 

Age

 < 70

33

16

17

0.446

 ≥ 70

27

16

11

 

Nephrectomy

Yes

36

19

17

0.563

No

24

13

11

 

T stage

T1-2

17

10

7

0.775

T3-4

43

22

21

 

WHO/ISUP grade

G1-2

23

14

9

0.430

G3-4

37

18

19

 

Recurrence

Yes

20

11

9

1.000

No

40

21

19

 

Metastasectomy

Yes

8

3

5

0.454

No

52

29

23

 

1st line treatment

Yes

29

19

10

0.077

No

31

13

18

 

IMDC risk

Favorable

9

5

4

0.731

Intermediate

28

16

12

 

Poor

22

10

12

 

NA

1

1

–

 
  1. ISUP international society of urological pathology, IMDC international metastatic renal cell carcinoma database consortium.
  2. Responders: patients with CR, PR, or SD ≥ 10 months.
  3. Non-responders: patients with PD or SD < 10 months.
Back to article page